Shukra Pharmaceuticals Ltd

₹ 103 -1.95%

04 Jul 3:46 p.m.

About

Incorporated in 1993, Shukra Pharmaceuticals Ltd manufactures and markets pharmaceutical products, and does laboratory testing^[1]

Key Points

Business Overview:^[1]^[2]
SPL is a is WHO-GMP certified integrated manufacturer of formulations like tablet, capsules and small volume parenteral. It has assisted in the development and manufacture
of a variety of drugs and dosage forms and potency variations for many pharmaceutical companies

Website BSE

Market Cap ₹ 451 Cr.
Current Price ₹ 103
High / Low ₹ 130 / 20.4
Stock P/E 24.3
Book Value ₹ 13.2
Dividend Yield 0.12 %
ROCE 44.2 %
ROE 44.7 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has reduced debt.
Company is almost debt free.
Company is expected to give good quarter
Company has delivered good profit growth of 109% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 30.3%

Cons

Stock is trading at 7.82 times its book value
Tax rate seems low
Working capital days have increased from 90.0 days to 160 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	4.26	2.96	2.98	2.89	8.94	6.57	3.72	2.30	46.25	20.16	24.64	18.89	10.88
	3.80	2.75	4.92	2.52	7.36	5.61	3.25	2.02	42.60	19.82	19.55	9.34	6.45
Operating Profit	0.46	0.21	-1.94	0.37	1.58	0.96	0.47	0.28	3.65	0.34	5.09	9.55	4.43
OPM %	10.80%	7.09%	-65.10%	12.80%	17.67%	14.61%	12.63%	12.17%	7.89%	1.69%	20.66%	50.56%	40.72%
	-0.35	0.23	2.40	0.13	0.04	0.01	0.03	0.27	0.89	0.63	0.24	0.56	1.38
Interest	0.03	0.02	0.02	0.04	0.21	0.12	0.04	0.05	0.07	0.08	0.06	0.07	0.07
Depreciation	0.39	0.37	0.37	0.37	0.56	0.42	0.45	0.46	0.51	0.46	0.56	0.51	0.52
Profit before tax	-0.31	0.05	0.07	0.09	0.85	0.43	0.01	0.04	3.96	0.43	4.71	9.53	5.22
Tax %	25.81%	20.00%	85.71%	44.44%	23.53%	23.26%	-700.00%	50.00%	-0.25%	2.33%	-0.21%	1.05%	23.75%
	-0.23	0.04	0.02	0.05	0.65	0.33	0.08	0.03	3.98	0.42	4.71	9.42	3.99
EPS in Rs	-0.05	0.01	0.00	0.01	0.15	0.07	0.02	0.01	0.90	0.10	1.09	2.18	0.91
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	5	4	3	5	5	5	6	12	11	20	59	75
	5	5	3	4	4	4	4	10	10	18	53	55
Operating Profit	0	-0	-0	1	1	2	2	2	1	3	5	19
OPM %	9%	-2%	-10%	24%	28%	30%	29%	13%	13%	14%	9%	26%
	-3	0	1	-0	0	0	0	0	0	0	1	3
Interest	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	1	1	1	0	0	1	1	1	1	2	2	2
Profit before tax	-3	-1	0	0	1	1	1	0	0	1	4	20
Tax %	0%	-9%	52%	66%	52%	45%	37%	82%	-90%	26%	1%	7%
	-3	-1	0	0	0	1	0	0	0	1	4	19
EPS in Rs	-0.09	-0.17	0.03	0.03	0.11	0.12	0.10	0.01	0.04	0.17	1.00	4.23
Dividend Payout %	0%	0%	0%	0%	16%	15%	17%	0%	0%	10%	4%	6%

Compounded Sales Growth
10 Years:	33%
5 Years:	67%
3 Years:	88%
TTM:	27%

Compounded Profit Growth
10 Years:	39%
5 Years:	109%
3 Years:	410%
TTM:	320%

Stock Price CAGR
10 Years:	%
5 Years:	107%
3 Years:	218%
1 Year:	130%

Return on Equity
10 Years:	14%
5 Years:	22%
3 Years:	30%
Last Year:	45%

Balance Sheet

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	10	2	2	2	2	2	2	2	2	2	4	11
Reserves	-11	12	12	13	13	13	14	14	14	15	21	47
	10	0	1	0	0	4	6	8	10	3	5	3
	4	4	3	3	4	6	7	10	10	15	45	17
Total Liabilities	14	18	18	17	19	24	28	34	36	35	75	78
	10	10	10	10	10	14	16	17	18	18	20	20
CWIP	0	2	2	2	2	2	2	2	2	2	2	2
Investments	0	0	0	0	0	0	0	0	0	0	0	0
	3	7	7	6	7	8	11	14	16	16	53	56
Total Assets	14	18	18	17	19	24	28	34	36	35	75	78

Cash Flows

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	-12	-3	-2	3	-0	1	0	1	1	8	3	-5
	2	-10	1	-0	-1	-5	-2	-3	-2	-2	-4	-1
	5	-18	1	-1	0	3	2	2	2	-7	5	12
Net Cash Flow	-5	-31	0	1	-1	-0	0	-0	0	-0	4	6

Ratios

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	92	45	73	71	175	200	345	245	318	132	187	120
Inventory Days	145	134	554	92	112	53	100	169	221	139	25	19
Days Payable	173	209	291	108	400	734	1,161	786	702	303	276	59
Cash Conversion Cycle	64	-30	335	54	-112	-480	-717	-372	-163	-32	-63	80
Working Capital Days	111	368	758	258	344	379	440	226	278	61	49	160
ROCE %	-2%	-6%	-1%	6%	7%	6%	4%	0%	1%	6%	19%

Shareholding Pattern

Numbers in percentages

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	49.17%	49.17%	49.17%	49.17%	49.17%	49.16%	49.16%	50.90%	50.90%	50.90%	50.95%	50.95%
	0.80%	0.80%	0.80%	0.80%	0.80%	0.80%	0.80%	0.11%	0.11%	0.11%	0.11%	0.11%
	50.04%	50.04%	50.04%	50.04%	50.04%	50.04%	50.04%	48.99%	48.99%	48.99%	48.93%	48.93%
No. of Shareholders	9,345	9,305	9,268	9,239	9,193	9,237	9,234	9,531	9,582	9,747	10,963	12,974

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	49.17%	49.17%	49.17%	49.17%	49.17%	49.17%	50.90%	50.95%
	0.80%	0.80%	0.80%	0.80%	0.80%	0.80%	0.11%	0.11%
	50.04%	50.04%	50.04%	50.04%	50.04%	50.04%	48.99%	48.93%
No. of Shareholders	9,706	9,577	9,468	9,455	9,345	9,239	9,531	12,974

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports